Depomed Inc (NASDAQ:DEPO)

6.78
Delayed Data
As of 4:00pm ET
 -0.24 / -3.42%
Today’s Change
4.31
Today|||52-Week Range
12.49
-15.78%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close7.02
Today’s open6.97
Day’s range6.67 - 7.08
Volume1,015,587
Average volume (3 months)1,215,573
Market cap$441.4M
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-12.41%
Earnings growth (this year)+70.74%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-16.49%
P/E ratioNM
Price/Sales1.33
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.50+6.78%
GLYCGlycoMimetics Inc-0.72-3.99%
AVEOAveo Pharmaceuticals...-0.11-3.99%
ACIUAC Immune SA+0.50+4.99%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$380.7M
Annual profit (last year)-$102.5M
Net profit margin-26.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Senior Vice President-Operations &
Business
Sean P. McKercher
Corporate headquarters
Newark, California

Forecasts